hers health - Search News

News

Wegovy, Hims & Hers Health and Novo Nordisk

The Wall Street Journal on MSN · 4d

Hims & Hers to Sell Novo Nordisk’s Wegovy in U.S., Shares Soar

Him & Hers Health and Novo Nordisk are collaborating to offer weight-loss treatment, including access to Wegovy along with other services to treat obesity.

WPLG Local 10 · 3d

Hims & Hers and other telehealth providers to start selling Wegovy

Drugmaker Novo Nordisk announced Tuesday that Wegovy will be available through telehealth providers. The providers -- Hims & Hers Health, Ro, and LifeMD -- will be shipping the weight-loss medication to patients’ homes.

Fox Business on MSN · 4d

Hims & Hers partners with Novo Nordisk to sell Wegovy

Hims & Hers on Tuesday announced a collaboration with drugmaker Novo Nordisk to bundle Wegovy and a Hims & Hers membership on its telehealth platform.

11hon MSN

Hims & Hers short interest at critical levels after best weekly gain: report

The short interest in Hims & Hers Health (NYSE:HIMS) has approached critical levels, financial data provider S3 Partners said ...

4don MSN

Why Hims & Hers Health and LifeMD Are Skyrocketing Today

Shares of Hims & Hers Health ( HIMS -5.48%) and LifeMD ( LFMD -14.33%) are surging on Tuesday. The companie' stocks had ...

2don MSN

Imitation weight-loss drugs boosted Hims & Hers. Executives cashed in.

Hims & Hers launched a pharmacy-made weight-loss drug last year, taking advantage of an FDA rule allowing it to temporarily ...

4d

Hims & Hers Health: GLP-1 Deals De-Risk The Story

Hims & Hers Health partners with Novo Nordisk (NVO) to offer Wegovy, boosting weight-loss solutions. See why I remain ...

8d

Breaking Down Hims & Hers Health: 13 Analysts Share Their Views

The 12-month price targets, analyzed by analysts, offer insights with an average target of $36.85, a high estimate of $68.00, ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results